Morbidity Rates of Q Fever in the Russian Federation and European Countries: Realities and Problems
https://doi.org/10.21055/0370-1069-2015-4-49-54
Abstract
Q fever poses a problem, both in the Russian Federation and abroad. Thereat, a new base normative document, sanitary-epidemiological regulations on coxiellosis prevention, has been developed and approved in the Russian Federation. For the first time ever in the world history, a regulated surveillance of community-acquired pneumonias, which will help to improve diagnostics of this pathology, has been introduced in our country. Quality of Q fever control directly depends on the laboratory facilities, qualification of the personnel, and coordination of interagency cooperation. All these factors provide for the prompt assessment of the situation, in-time anti-epidemic measures, and forecasting of the events, which ensures the biological security of Russian Federation.
About the Authors
E. A. Yakovlev
The 48th Central Research Institute of the RF Ministry of Defense
Russian Federation
Russian Federation
S. V. Borisevich
The 48th Central Research Institute of the RF Ministry of Defense
Russian Federation
Russian Federation
A. Yu. Popova
Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare; Russian Medical Academy for Post-Graduate Training
Russian Federation
Russian Federation
E. B. Ezhlova
Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Russian Federation
Russian Federation
Yu. V. Demina
Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Russian Federation
Russian Federation
References
1. Bogomolov B.P. [Infectious Diseases: Urgent Diagnostics, Treatment, and Prophylaxis]. M.: “Newdiamed”; 2007. 653 p.
2. Karpenko S.F., Galimzyanov Kh.M., Kasimova N.V., Rubal’sky O.V., Kraskov A.V., Goreva O.N. [Age-specific aspects of the clinical-immunological manifestations of Q fever]. Epidemiol. Infek. Bol. 2012; 6:16–9.
3. Loban K.M., Lobzin Yu.V., Lukin E.P. [Human Rickettsioses (Guidelines for Clinicians)].M. – St. Petersburg; 2002. 480 p.
4. Onishchenko G.G., Monisov A.A., Gul’chenko L.P. [Morbidity rates on anthropozoonoses and natural-focal infections and measures for their prophylaxis]. Zh. Mikrobiol. Epidemiol. Immunobiol. 1999; 4:14–8.
5. Rudakov N.V. [Taxonomy, ecology and evolutional relations of rickettsia]. RAS Bulletin. 2008; 7: 10-5.
6. Rybakova N.A., Sochnev V.V. [Zoonotic diseases under the conditions of European North of Russia]. Epidemiol. Infek. Bol. 1998; 2:12–6.
7. [Prophylaxis of coxiellosis (Q fever). Sanitary-epidemiological regulations]. SR 3.1.7.2811–10. M.; 2010. 26 p.
8. Smelyansky V.P., Korsakova I.I., Pashanina T.P., Mananenkov V.V., Savchenko S.T., Shumakevich G.V., Ioannidi E.A., Bozhko V.G., Popov S.F. [ Morbidity rates on Q fever among the population of the Volgograd Region]. Infek. Bol. 2012; 10(2):29–32.
9. Tokarevich N.K. [Academician of the Russian Academy of Medical Sciences, I.V. Tarasevich – the Head of the Project on the development of combined inactivated vaccine against Q fever (coxiellosis)]. RAMS Bulletin. 2008; 7:19–24.
10. Yakovlev E.A., Lukin E.P., Borisevich S.V. [Chemotherapy and chemoprophylaxis of rickettsioses and Q fever at the present stage]. Antibiot. Khimioter. 2011; 56(11–12):34–44.
11. Berg E.J., Wielders C.C.H., Schneeberger P.M., Wegdam-Blans M. C., Hoek W. Spatial analysis of positive and negative Q fever laboratory results for identifying high-and low-risk areas of infection in the Netherlands. Infect. Ecol. Epidemiol. 2013; 3:1–7.
12. Bielawska-Drozd A., Cieslik P., Mirski T., Bartoszcze M., Knap J.P., Gawel J., Zakowska D. Q fever-selected issues. Ann. Agr. Environ. Med. 2013; 20 (2):222–32.
13. Brooke R.J., Kretzschmar M.E.E., Mutters N.T., Teunis P.F. Human dose respons relation for airborne exposure to Coxiella burnetii. BMC Infect. Dis. 2013; 13(488):1–8.
14. Brooke R.J., Schneeberger P.M., Hoek W. Q fever in the Netherlands? A review. Culture. 2011; 32 (1):5–7.
15. Caron F., Meurice J.C., Ingrand P., Bourgoin A., Masson P., Roblot P., Patte F. Acute Q fever pneumonia: a review of 80 hospitalized patients. Chest. 1998; 114(3):808–13.
16. С hmielewski T. Q fever outbreaks in Poland during 2005–2011. Med. Sci. Monit. 2013; 19:1073–9.
17. Delsing C.E., Kullberg B.J. Q fever in the Netherlands: a concise overview and implications of the largest ongoing outbreak. Netherlands J. Med. 2008; 66 (9):365–7.
18. Frankel D., RichetnH., Renvoise A., Raoult D. Q fever in France, 1985–2009. Emerg. Infect. Dis. 2011; 17(3):350–5.
19. Hellenbrand W., Breuer T., and Petersen L. Changing Epidemiology of Q Fever in Germany, 1947–1999. Emerg. Infect. Dis. 2001; 7(5):789–96.
20. Hoek W., Schneeberger P.M., Oomen T., Wegdam-Blans M.C., Dijkstra F., Notermans D.W., Bijlmer H.A., Groeneveld K., Wijkmans C.J., Rietveld A., Kampschreur L., Duynhoven Y. Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in the Netherlands: from acute to chronic infection. Euro Surveill. 2012; 17(3):pii=20059.
21. Kamenov G, Tiholova M. Q fever outbreak in Botevgrad, Bulgaria: May–June 2004. Euro Surveill. 2004; 8(35):pii=2535.
22. Monno R., Fumarola L., Trerotoli P., Cavone D., Giannelli G., Rizzo C., Ciceroni L., Musti M. Seroprevalence of Q fever, brucellosis and leptospirosis in farmers and agricultural workers in Bari, Southern Italy. Ann. Agric. Environ. Med. 2009; 19:205–9.
23. Porten K., Rissland J., Tigges A., Broll S., Hopp W., Lunemann M., Treeck U., Kimmig P., Brockmann S.O., Wagner–Wiening C., Hellenbrand W., Buchholz U. A super-spreading ewe infects hundreds with Q fever at a farmers market in Germany. BMC Infect. Dis. 2006; 6(10):147.
24. Roest H.I.J., Solt C.B., Tilburg J.H.C., Klassen C.H.W., Hovius E.K., Roest F.T.F., Vellema P., Brom R., Zijderveld F.G. Search for Passible Additional Reservoirs for Human Q fever, the Netherlands. Emerg. Infect. Dis. 2013; 19(5):834–5.
25. Rooij M.M.T., Schimmer B., Versteeg B., Schneeberger P., Berends B. R., Heederik D., Hoek W., Wouters I.M. Risk Factors of Coxiella burnetii (Q fever) seropositivity in veterinary medicine students. PLoS ONE. 2012; 7(2):e32108.
26. Santoro D., Giura R., Colombo M.C., Antonelli P., Gramegna M., Gandola O., Gridavilla G. Q fever in Como, North Italy. Emerg. Infect. Dis. 2004; 10(1):157–8.
27. Serbezov V.S., Kazar J., Novkirishki V., Gatcheva N., Kovacova E., Yoynova V. Q fever in Bulgaria end Slovakia. Emerg. Infect. Dis. 1999; 5(3):388–94.
28. Skerget M., Wenisch C., Daxboeck F.,Krause R., Haberl R., Stuenzner D. Cat or Dog Ownership and Seroprevalence of Ehrlichiosis, Q Fever, and Cat-Scratch Disease. Emerg. Infect. Dis. 2003; 9(10):1337–40.
29. Smith D.L., Ayres J.G., Blair I., Burge P.S., Carpenter M.J., Caul E.O., Coupland B., Desselberger U., Evans M , Farrel I.D. A large Q fever outbreak in the west Midlands: clinical aspects. Resp. Med. 1993; 87:509–16.
30. Tissout-Dupont H., Amadei M., Nezzi M. and Raoult D. Wind in November, Q fever in December. Emerg. Infect. Dis. 2004; 10(9):1264–9.
31. Wattiau P., Baldisova E., Toman R., Esbroeck M., Quoilin S., Hammadi S. , Tissout – Dupont H., Raoult D., Henkinbrant J.M., Hessche M., Fretin D. Q fever in Woolsorters, Belgium. Emerg. Infect. Dis. 2011; 17(12):2368–9.
32. Woerden H.C., Mason B.M., Nehaul L.K., Smith R., Salmon R.L., Healy B. , Valappil M., Westmoreland D., Martin S., Evans M.R., Lloyd G., Hamilton – Kirkwood M., Williams N.S. Q fever outbreak in industrial setting. Emerg. Infect. Dis. 2004; 10(7):1282–9.
Review
For citations:
Yakovlev E.A., Borisevich S.V., Popova A.Yu., Ezhlova E.B., Demina Yu.V. Morbidity Rates of Q Fever in the Russian Federation and European Countries: Realities and Problems. Problems of Particularly Dangerous Infections. 2015;(4):49-54. (In Russ.) https://doi.org/10.21055/0370-1069-2015-4-49-54
Views:
759
Email this article 